Skip to content

Comparison of the effectiveness of local administration of magnesium sulfate in the latent phase of labor on the improvement of effacement, dilatation, and duration of labor in primiparous and multiparous women

Comparison of the effectiveness of local administration of magnesium sulfate in the latent phase of labor on the improvement of effacement, dilatation, and duration of labor in primiparous and multiparous women

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20231121060128N1
Enrollment
75
Registered
2024-01-01
Start date
2024-01-10
Completion date
Unknown
Last updated
2024-01-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Improvement of dilation, effacement of cervix , and labor duration.

Interventions

Intervention 1: Ten cc of 50% magnesium sulfate (up to two doses) will be poured between the fingers on the cervix during the vaginal examination during the latent phase of labor to cover the entire c

Sponsors

Zanjan University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 45 Years

Inclusion criteria

Inclusion criteria: Singleton pregnancy Cephalic presentation Gestational age, 37-42 weeks Dilatation less than 3 cm Body mass index between 19.8 and 30 kg/m2 Low risk pregnancy

Exclusion criteria

Exclusion criteria: The infertility treatments in a recent pregnancy Multiple pregnancy History or heart disease in recent pregnancy Having a history of severe allergy to magnesium sulfate The existence of contraindications for natural childbirth, including fetal heart rate disorders, placental abruption, umbilical cord prolapse known pelvic stenosis disorder before the start of labor

Design outcomes

Primary

MeasureTime frame
Cervical effacement, dilation, and duration of labor. Timepoint: Before the intervention, 4 hours and then 8 hours after the intervention. Method of measurement: Vaginal examination.;Hemoglobin and hematocrit. Timepoint: 24 hours after delivery. Method of measurement: blood test.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactZahra Rahmi

Zanjan University of Medical Sciences

z.rahemi@yahoo.com+98 24 3313 0000

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026